U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07788482) titled 'Study on the Mass Balance of [14C] CMS-D002 in Healthy Adult Participants in China' on Aug. 11.
Brief Summary: This phase 1, single-group study will evaluate the mass balance of [14C] CMS-D002 after a single oral dose in healthy adult participants in China. The study will assess total radioactivity recovery and routes of excretion, characterize whole-blood and plasma pharmacokinetics, and determine metabolite profiles and major biotransformation pathways.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: [14C] CMS-D002
Single oral dose administration of [14C] CMS-D002....